- 1
-
Ragulina V.A., Kostina D.A., Dovgan A.P., Burda Y.E., Nadezhdin S.V. Nuclear factor kappa B as a potential target for pharmacological correction endothelium-associated pathology. Research result: pharmacology and clinical pharmacology. 2017; 3(1): 114124. DOI: 10.18413/2500-235X-2017-3-1-114-124
(check this in PDF content)
- 2
-
Konstantinidis L., Guex-Crosier Y. Hypertension and the eye. Curr Opin Ophthalmol. 2016; 27(6): 514-521. DOI: 10.1097/ ICU.0000000000000307
(check this in PDF content)
- 3
-
Wong T.Y., Mitchell P. Hypertensive retinopathy. N Engl J Med. 2004; 351: 2310–2317. DOI: 10.1056/NEJMra032865
(check this in PDF content)
- 4
-
Khurana A.R., Khurana B., Chauhan S., et al. Hypertensive retinopathy an overview. Haryana J. Ophthalmol. 2014; 7: 64-66.
(check this in PDF content)
- 5
-
Cuspidi C., Macca G., Salerno M., et al. Evaluation of target organ damage in arterial hypertension: which role for qualitative funduscopic examination? Ital Heart J. 2001; 2(9): 702-706.
(check this in PDF content)
- 6
-
Cuspidi C., Meani S., Valerio C., et al. Prevalence and correlates of advanced retinopathy in a large selected hypertensive population. The Evaluation of Target Organ Damage in Hypertension (ETODH) study. Blood Press. 2005; 14(1): 25-31. DOI: 10.1080/08037050510008805
(check this in PDF content)
- 7
-
Kolman S.A., van Sijl A.M., van der Sluijs F.A., van de Ree M.A. Consideration of hypertensive retinopathy as an important end-organ damage in patients with hypertension. J Hum Hypertens. 2017; 31(2): 121-125. DOI: 10.1038/jhh.2016.49
(check this in PDF content)
- 8
-
Shabelnikova A.S. Correction of ischemic damage to the retina on application of pharmacological preconditioning of recombinant erythropoietin. Research result: pharmacology and clinical pharmacology. 2016; 2(2): 67-90. DOI: 10.18413/2313-8971-20162-2-67-90
(check this in PDF content)
- 9
-
Peresypkina A.A., Gubareva V.O., Levkova E.A., Shabelnikova A.S. Correction of retinal angiopathy of hypertensive type by minoxidil, sildenafil in experiment. Research result: pharmacology and clinical pharmacology. 2016; 2(4): 34-44. DOI: 10.18413/2500235X-2016-2-4-34-44
(check this in PDF content)
- 10
-
Shabelnikova A.S., Lutsenko V.D., Pokrovskii M.V., Peresipkina A.A., Korokin M.V., Gudyrev O.S., Pokrovskaia T.G., Beskhmelnitsyna E.A., Hoshenko Y.A. Protective effects of recombinant erythropoietin in ischemia of the retina: the role of mechanisms of preconditioning. Research Journal of Medical Sciences. 2015; 9(4): 200-203. DOI: 10.3923/rjmsci.2015.200.203
(check this in PDF content)
- 11
-
Zahng, L., Gu, Y.-h., An, J., et al. Effects of the duration of dark adaptation on the retinal function of normal SD rats. Chinese journal of optometry ophthalmology and visual science. 2013; 15(6): 323-326. Поступила / Received 27.11.2017
(check this in PDF content)